#RNAprofiling adds clinical value in cancer therapy: ≥6 altered genes link to shorter survival, while #TP53 mutations correlate with #VEGFA overexpression, suggesting possible #bevacizumab sensitivity. @mdanderson.bsky.social

#OpenAccess in #STTT: doi.org/10.1038/s413...